Stress Awareness Day Research: Cortisol, Sleep and Evidence-Based Recovery
Stress Awareness Day research examines how nervous-system responses, cortisol rhythms, sleep, work conditions and social context inf...
One Health Day Research: Zoonoses, Antimicrobial Resistance and Environmental Surveillance
One Health Day research examines how human, animal and environmental health intersect. On November 3, the evidence-based focus is on...
Reproductive Health Research: Fertility Biomarkers, Trials and Evidence
Reproductive health research examines ovulation, sperm production, clinical outcomes and the many factors that influence fertility. ...
World Vegan Day Nutrition Research: Protein, B12 and Diet Quality
World Vegan Day nutrition research is best understood through actual dietary composition, nutrient adequacy, and measured outcomes. ...
Iodine and Thyroid Research: Deficiency, Nutrition and Clinical Evidence
Iodine and thyroid research examines the relationship between dietary iodine, thyroid hormone production and lifelong health. For Wo...
Food Safety and Nutrition Research: Evidence for Healthier Kitchens
Food safety and nutrition research connects the science of foodborne hazards with the work of chefs, food handlers and public-health...
Pediatric Musculoskeletal Research: Growth Plates, Bone Health and Sports Injuries
Pediatric musculoskeletal research examines how growing bones, joints and connective tissues respond to development, physical activi...
Retatrutide Triple-Agonist Research: Clinical Evidence, Safety and Canada Status
Retatrutide clinical research examines an investigational triple receptor agonist that targets GIP, GLP-1 and glucagon signalling. T...
Social Determinants of Health Research: Poverty, Nutrition and Health Outcomes
Social determinants of health research helps explain how poverty, food security, housing and employment shape population outcomes. F...
Petrelintide in ZUPREME-2: Weight Loss, Gut Tolerability and the Next Amylin Test
petrelintide produced 7.4–9.2% mean weight loss in ZUPREME-2. Read the company-reported 28-week results, tolerability limits and next trials.